Short interest in Cullinan Therapeutics Inc (NASDAQ:CGEM) decreased during the last reporting period, falling from 9.78M to 8.73M. This put 17.39% of the company's publicly available shares short.

Short interest for Cullinan Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Cullinan Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 421.65K shares traded per day, it would take 20.71 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.